EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0RKL: Xvivo Perfusion AB

29 Aug 2025
LAST:

169.5

CHANGE:
 6.43		OPEN:
174.0		HIGH:
174.0		ASK:
0.0		VOLUME:
9.2K
CHG(%):
3.65		PREV:
175.9		LOW:
167.7		BID:
0.0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Aug 25174.0174.0167.7169.59.2K
28 Aug 25175.6177.4174.6175.97K
27 Aug 25175.3176.0171.9173.037.9K
26 Aug 25179.4181.2175.8178.75.6K
25 Aug 25177.5182.2174.6180.810.7K
22 Aug 25177.5182.2174.6180.89.5K
21 Aug 25178.4178.4176.0177.810.1K
20 Aug 25180.6181.4177.6180.13.9K
19 Aug 25184.2184.8182.7182.71.9K
18 Aug 25184.3185.1179.2180.65.4K

COMPANY PROFILE

Name:Xvivo Perfusion AB
About:Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.
Address:Gemenskapens gata 9, Mölndal, Sweden, 431 53
Website:https://www.xvivogroup.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

P/E Ratio:7.42
PtS:5.66
EBITDA:95.2M
Shares:26.4M
Market Cap:4.476B

TECHNICAL INDICATORS

MA5:175.58
MA10:177.99
MA20:183.21
MA50:222.23
MA100:263.11
MA200:347.88
RSI14:34.19
WPR14:-100.00
MTM14:-12.48
ROC14:-0.07
ATR:6.10
Week High:182.20
Week Low:167.70
Month High:206.20
Month Low:167.70
Year High:535.00
Year Low:167.70
Volatility:51.67